Fig 5 - by Thomas Jacquet (9960275)

Differentially expressed nonmitochondrial proteins (DEP) with decreased expression comparing horses susceptible to recurrent exertional rhabdomyolysis with control. by Kennedy Aldrich (10125669)

Differentially expressed mitochondrial proteins (DEP) with decreased expression comparing horses susceptible to recurrent exertional rhabdomyolysis with control. by Kennedy Aldrich (10125669)

Vesicle <i>p</i>H fluctuations are constant over a range of <i>p</i>H values. by Apeksha Singh (8174256)

CX treatment leads to decreased perfusion and increased leakage after VEGF-A induced angiogenesis. by Mattias Kalén (224600)

24 h fasting decreases mARC protein levels and <i>N</i>-reductive activity in mice. by Heyka H. Jakobs (619421)

Fig 5 - by Qingxi Shen (3547970)

Decrease in the mean age at onset of T2DM across different BMI categories in hypertensive and non-hypertensive patients. by Arshad Mohamed Channanath (553879)

Steady-state kinetic analysis of <i>Pf</i>CCT MΔK^WT and <i>Pf</i>CCT MΔK^R681H. by Lívia Marton (756117)

“…<p>A) CTP titration of the activity of the CCTs at a fixed ChoP concentration of 5 mM. …”

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

GPT-4 results in decreased error rate for all tasks with increasing complexity when compared to GPT-3.5-turbo. by Jacqueline A. Jansen (14894276)

Schematic diagram of the track and latch comparator (a) conventional track and latch comparator (b) small signal model of the comparator. by Labonnah Farzana Rahman (641767)

Tunicamycin produces a concentration- and time-dependent decrease in cell viability in SH-SY5Y cells concomitant with caspase-3 activation. by Arindam P. Ghosh (317870)

“…<p>(A) Treatment of SH-SY5Y cells with tunicamycin (0.1–5µM) for 24 h caused a progressive decrease in cell viability as measured by Calcein AM cleavage assay. …”

Mitochondrial dysfunction is driven by decreased mitochondrial dynamics. by Piero Dalle Pezze (622889)

“…<p>(A) Sensitivity analysis averaged along the time course for the mitochondrial species in the model by varying the mitochondrial-related kinetic rate constant parameters. …”

Replacement of <i>RPL22B</i> promoter by the GAL promoter results in a decrease in alternative 5′-splice site usage. by Tadashi Kawashima (550396)

TR4 and TR9 decrease hepatoma cell viability at a lower TC50 than Sorafenib, SAHA or 5-Fluorouracil. by Nicole Lange (335740)

Binding sensogram (a) showing decrease in frequency of crystal immobilised with 1.5 M short aptamer exposed to different concentrations of heparanase. by Suzanne C. Simmons (319222)

“…<p>Higher concentrations of heparanase exhibited a greater decrease in frequency. Binding and regeneration sensogram (b) for addition of 800 nM heparanase to a quartz crystal immobilised with 1.5 M short aptamer. …”

Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)

Predicting alternans in the V_m-driven model during a progressive decrease of I_Ks conductance. by Mathieu Lemay (330649)

Image_5_Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.TIF by Rohit Moudgil (540119)